Clinical Trial Update: Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a novel exhalational delivery system delivering fluticasone (EDS-FLU) for Eustachian tube dysfunction, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eustachian Tube Dysfunction

Drugs mentioned

• EDS-FLU (fluticasone)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Eustachian Tube Dysfunction | Phase 2 | Status: RECRUITING